Recent advances toward the discovery of drug-like peptides de novo

Frontiers in Chemistry

Volumn 3, Issue DEC, 2015, Pages

  Goldflam, Michael ^a   Ullman, Christopher G ^b  

^a The Mansion   (United Kingdom)

^b Paratopix Ltd   (United Kingdom)

Author keywords

Cyclic peptides; Directed evolution; Display systems; Non natural amino acids; Peptide drug discovery; Peptides and derivatives; Stability

Indexed keywords

EID: 84969506943     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2015.00069     Document Type: Short Survey

References (77)

1. Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó-Vila, M., Giordano, R. J., et al. (2002). Steps toward mapping the human vasculature by phage display. Nat. Med. 8, 121-127. doi: 10.1038/nm0202-121
2. Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., et al. (2008). Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew. Chem. Int. Ed. Engl. 47, 2595-2599. doi: 10.1002/anie.200705797
3. Bockus, A. T., McEwen, C. M., and Lokey, R. S. (2013). Form and function in cyclic peptide natural products: a pharmacokinetic perspective. Curr. Top. Med. Chem. 13, 821-836. doi: 10.2174/1568026611313070005
4. Breitling, F., Nesterov, A., Stadler, V., Felgenhauer, T., and Bischoff, F. R. (2009). High-density peptide arrays. Mol. Biosyst. 5, 224-234. doi: 10.1039/b819850k
5. Chen, S., Gopalakrishnan, R., Schaer, T., Marger, F., Hovius, R., Bertrand, D., et al. (2014). Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides. Nat. Chem. 6, 1009-1016. doi: 10.1038/nchem.2043
6. Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., et al. (2006). Transderml protein delivery by a coadministered peptide identified via phage display. Nat. Biotechnol. 24, 455-460. doi: 10.1038/nbt1193
7. Chin, J. W. (2011). Reprogramming the genetic code. EMBO J. 30, 2312-2324. doi: 10.1038/emboj.2011.160
8. Craik, D. J., Fairlie, D. P., Liras, S., and Price, D. (2013). The future of peptide-based drugs. Chem. Biol. Drug Des. 81, 136-147. doi: 10.1111/cbdd.12055
9. Cromm, P. M., Spiegel, J., and Grossmann, T. N. (2015). Hydrocarbon stapled peptides as modulators of biological function. ACS Chem. Biol. 10, 1362-1375. doi: 10.1021/cb501020r
10. Daugherty, P. S. (2007). Protein engineering with bacterial display. Curr. Opin. Struct. Biol. 17, 474-480. doi: 10.1016/j.sbi.2007.07.004
11. Douthwaite, J. A., and Jackson, R. H. (2012). Ribosome Display and Related Technologies: Methods and Protocols. Totowa, NJ: Humana.
12. Duerr, D. M., White, S. J., and Schluesener, H. J. (2004). Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier. J. Virol. Methods 116, 177-180. doi: 10.1016/j.jviromet.2003.11.012
13. Eldridge, B., Cooley, R. N., Odegrip, R., McGregor, D. P., Fitzgerald, K. J., and Ullman, C. G. (2009). An in vitro selection strategy for conferring protease resistance to ligand binding peptides. Protein Eng. Des. Sel. 22, 691-698. doi: 10.1093/protein/gzp052
14. Frenkel, D., and Solomon, B. (2002). Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl. Acad. Sci. U.S.A. 99, 5675-5679. doi: 10.1073/pnas.072027199
15. Frost, J. R., Jacob, N. T., Papa, L. J., Owens, A. E., and Fasan, R. (2015). Ribosomal synthesis of macrocyclic peptides in vitro and in vivo mediated by genetically encoded aminothiol unnatural amino acids. ACS Chem. Biol. 10, 1805-1816. doi: 10.1021/acschembio.5b00119
16. Gai, S. A., and Wittrup, K. D. (2007). Yeast surface display for protein engineering and characterization. Curr. Opin. Struct. Biol. 17, 467-473. doi: 10.1016/j.sbi.2007.08.012
17. Gao, C., Mao, S., Ditzel, H. J., Farnaes, L., Wirsching, P., Lerner, R. A., et al. (2002). A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. Bioorg. Med. Chem. 10, 4057-4065. doi: 10.1016/S0968-0896(02)00340-1
18. Geysen, H. M., and Mason, T. J. (1993). Screening chemically synthesized peptide libraries for biologically-relevant molecules. Bioorg. Med. Chem. Lett. 3, 397-404. doi: 10.1016/S0960-894X(01)80221-3
19. Giordanetto, F., and Kihlberg, J. (2014). Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? J. Med. Chem. 57, 278-295. doi: 10.1021/jm400887j
20. Giordano, R. J., Cardó-Vila, M., Salameh, A., Anobom, C. D., Zeitlin, B. D., Hawke, D. H., et al. (2010). From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway. Proc. Natl. Acad. Sci. U.S.A. 107, 5112-5117. doi: 10.1073/pnas.0915141107
21. Goto, Y., Ito, Y., Kato, Y., Tsunoda, S., and Suga, H. (2014). One-pot synthesis of azoline-containing peptides in a cell-free translation system integrated with a posttranslational cyclodehydratase. Chem. Biol. 21, 766-774. doi: 10.1016/j.chembiol.2014.04.008
22. Goto, Y., Katoh, T., and Suga, H. (2011). Flexizymes for genetic code reprogramming. Nat. Protoc. 6, 779-790. doi: 10.1038/nprot.2011.331
23. Gould, A., Ji, Y., Aboye, T. L., and Camarero, J. A. (2011). Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery. Curr. Pharm. Des. 17, 4294-4307. doi: 10.2174/138161211798999438
24. Greenwood, K. P., Daly, N. L., Brown, D. L., Stow, J. L., and Craik, D. J. (2007). The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int. J. Biochem. Cell Biol. 39, 2252-2264. doi: 10.1016/j.biocel.2007.06.016
25. Hamzeh-Mivehroud, M., Alizadeh, A. A., Morris, M. B., Church, W. B., and Dastmalchi, S. (2013). Phage display as a technology delivering on the promise of peptide drug discovery. Drug Discov. Today 18, 1144-1157. doi: 10.1016/j.drudis.2013.09.001
26. Hanes, J., and Plückthun, A. (1997). In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. U.S.A. 94, 4937-4942.
27. Hartman, M. C., Josephson, K., Lin, C. W., and Szostak, J. W. (2007). An expanded set of amino acid analogs for the ribosomal translation of unnatural peptides. PLoS ONE 2:e972. doi: 10.1371/journal.pone.0000972
28. Heinis, C., Rutherford, T., Freund, S., and Winter, G. (2009). Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nat. Chem. Biol. 5, 502-507. doi: 10.1038/nchembio.184
29. Hofmann, F. T., Szostak, J. W., and Seebeck, F. P. (2012). In vitro selection of functional lantipeptides. J. Am. Chem. Soc. 134, 8038-8041. doi: 10.1021/ja302082d
30. Hoogenboom, H. R. (2005). Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105-1116. doi: 10.1038/nbt1126
31. Jagadish, K., Gould, A., Borra, R., Majumder, S., Mushtaq, Z., Shekhtman, A., et al. (2015). Recombinant expression and phenotypic screening of a bioactive cyclotide against alpha-synuclein-induced cytotoxicity in baker's yeast. Angew. Chem. Int. Ed. Engl. 54, 8390-8394. doi: 10.1002/anie.201501186
32. Jin, L., and Harrison, S. C. (2002). Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin. Proc. Natl. Acad. Sci. U.S.A. 99, 13522-13526. doi: 10.1073/pnas.212504399
33. Kaspar, A. A., and Reichert, J. M. (2013). Future directions for peptide therapeutics development. Drug Discov. Today 18, 807-817. doi: 10.1016/j.drudis.2013.05.011
34. Kastin, A. J. (2006). Handbook of Biologically Active Peptides. Amsterdam; London: AcademicPress.
35. Kessler, H., Köck, M., Wein, T., and Gehrke, M. (1990). Reinvestigation of the conformation of cyclosporin A in chloroform. Helv. Chim. Acta 73, 1818-1832.
36. Knerr, P. J., and van der Donk, W. A. (2012). Discovery, biosynthesis, and engineering of lantipeptides. Annu. Rev. Biochem. 81, 479-505. doi: 10.1146/annurev-biochem-060110-113521
37. Ko, S. Y., and Dalvit, C. (1992). Conformation of cyclosporin A in polar solvents. Int. J. Pept. Protein Res. 40, 380-382.
38. Kritzer, J. A., Hamamichi, S., McCaffery, J. M., Santagata, S., Naumann, T. A., Caldwell, K. A., et al. (2009). Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models. Nat. Chem. Biol. 5, 655-663. doi: 10.1038/nchembio.193
39. Krumpe, L. R., and Mori, T. (2007). Potential of phage-displayed peptide library technology to identify functional targeting peptides. Expert Opin. Drug Discov. 2, 525. doi: 10.1517/17460441.2.4.525
40. Lam, K. S., Hruby, V. J., Lebl, M., Knapp, R. J., Kazmierski, W. M., Hersh, E. M., et al. (1993). The chemical synthesis of large random peptide libraries and their use for the discovery of ligands for macromolecular acceptors. Bioorg. Med. Chem. Lett. 3, 419-424. doi: 10.1016/S0960-894X(01)80224-9
41. Levin, A. M., and Weiss, G. A. (2006). Optimizing the affinity and specificity of proteins with molecular display. Mol. Biosyst. 2, 49-57. doi: 10.1039/b511782h
42. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26. doi: 10.1016/S0169-409X(96)00423-1
43. Loosli, H. R., Kessler, H., Oschkinat, H., Weber, H. P., Petcher, T. J., and Widmer, A. (1985). The conformation of cyclosporin A in the crystal and in solution. Helv. Chim. Acta 68, 682-704.
44. Macdougall, I. C., Rossert, J., Casadevall, N., Stead, R. B., Duliege, A. M., Froissart, M., et al. (2009). A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia. N. Engl. J. Med. 361, 1848-1855. doi: 10.1056/NEJMoa074037
45. Mattheakis, L. C., Bhatt, R. R., and Dower, W. J. (1994). An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc. Natl. Acad. Sci. U.S.A. 91, 9022-9026.
46. McLafferty, M. A., Kent, R. B., Ladner, R. C., and Markland, W. (1993). M13 bacteriophage displaying disulfide-constrained microproteins. Gene 128, 29-36.
47. Millward, S. W., Fiacco, S., Austin, R. J., and Roberts, R. W. (2007). Design of cyclic peptides that bind protein surfaces with antibody-like affinity. ACS Chem. Biol. 2, 625-634. doi: 10.1021/cb7001126
48. Millward, S. W., Takahashi, T. T., and Roberts, R. W. (2005). A general route for post-translational cyclization of mRNA display libraries. J. Am. Chem. Soc. 127, 14142-14143. doi: 10.1021/ja054373h
49. Nemoto, N., Miyamoto-Sato, E., Husimi, Y., and Yanagawa, H. (1997). In vitro virus: bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett. 414, 405-408.
50. Obrecht, D., C. E., Moehle, K., and Robinson, J. (2012). beta-Hairpin protein epitope mimetic technology in drug discovery. Drug Discov. Today Technol. 9, e1-e70. doi: 10.1016/j.ddtec.2011.07.006
51. Odegrip, R., Coomber, D., Eldridge, B., Hederer, R., Kuhlman, P. A., Ullman, C., et al. (2004). CIS display: in vitro selection of peptides from libraries of protein-DNA complexes. Proc. Natl. Acad. Sci. U.S.A. 101, 2806-2810. doi: 10.1073/pnas.0400219101
52. Ohta, A., Murakami, H., Higashimura, E., and Suga, H. (2007). Synthesis of polyester by means of genetic code reprogramming. Chem. Biol. 14, 1315-1322. doi: 10.1016/j.chembiol.2007.10.015
53. Ohuchi, M., Murakami, H., and Suga, H. (2007). The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus. Curr. Opin. Chem. Biol. 11, 537-542. doi: 10.1016/j.cbpa.2007.08.011
54. O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., and DeGrado, W. F. (1992). Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins 14, 509-515. doi: 10.1002/prot.340140411
55. Otvos, L. Jr., and Wade, J. D. (2014). Current challenges in peptide-based drug discovery. Front. Chem. 2:62. doi: 10.3389/fchem.2014.00062
56. Passioura, T., Katoh, T., Goto, Y., and Suga, H. (2014). Selection-based discovery of druglike macrocyclic peptides. Annu. Rev. Biochem. 83, 727-752. doi: 10.1146/annurev-biochem-060713-035456
57. Patel, S., Mathonet, P., Jaulent, A. M., and Ullman, C. G. (2013). Selection of a high-affinity WW domain against the extracellular region of VEGF receptor isoform-2 from a combinatorial library using CIS display. Protein Eng. Des. Sel. 26, 307-315. doi: 10.1093/protein/gzt003
58. Rackham, O., and Chin, J. W. (2005). A network of orthogonal ribosome x mRNA pairs. Nat. Chem. Biol. 1, 159-166. doi: 10.1038/nchembio719
59. Reichart, J. (2010). Development Trends for Peptide Therapeutics. 2010 Report. Available online at: http://www.peptidetherapeutics.org/
60. Reid, P. C., Goto, Y., Katoh, T., and Suga, H. (2012). Charging of tRNAs using ribozymes and selection of cyclic peptides containing thioethers. Methods Mol. Biol. 805, 335-348. doi: 10.1007/978-1-61779-379-0_19
61. Roberts, R. W., and Szostak, J. W. (1997). RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. U.S.A. 94, 12297-12302.
62. Rockberg, J., Löfblom, J., Hjelm, B., Uhlén, M., and Ståhl, S. (2008). Epitope mapping of antibodies using bacterial surface display. Nat. Methods 5, 1039-1045. doi: 10.1038/nmeth.1272
63. Schlippe, Y. V., Hartman, M. C., Josephson, K., and Szostak, J. W. (2012). In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors. J. Am. Chem. Soc. 134, 10469-10477. doi: 10.1021/ja301017y
64. Seebeck, F. P., Ricardo, A., and Szostak, J. W. (2011). Artificial lantipeptides from in vitro translations. Chem. Commun. 47, 6141-6143. doi: 10.1039/c0cc05663d
65. Sergeeva, A., Kolonin, M. G., Molldrem, J. J., Pasqualini, R., and Arap, W. (2006). Display technologies: application for the discovery of drug and gene delivery agents. Adv. Drug Deliv. Rev. 58, 1622-1654. doi: 10.1016/j.addr.2006.09.018
66. Shimizu, Y., Inoue, A., Tomari, Y., Suzuki, T., Yokogawa, T., Nishikawa, K., et al. (2001). Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19, 751-755. doi: 10.1038/90802
67. Shimizu, Y., Kanamori, T., and Ueda, T. (2005). Protein synthesis by pure translation systems. Methods 36, 299-304. doi: 10.1016/j.ymeth.2005.04.006
68. Sidhu, S. S., Lowman, H. B., Cunningham, B. C., and Wells, J. A. (2000). Phage display for selection of novel binding peptides. Methods Enzymol. 328, 333-363.
69. Smith, G. P., and Petrenko, V. A. (1997). Phage display. Chem. Rev. 97, 391-410.
70. Subtelny, A. O., Hartman, M. C., and Szostak, J. W. (2008). Ribosomal synthesis of N-methyl peptides. J. Am. Chem. Soc. 130, 6131-6136. doi: 10.1021/ja710016v
71. Subtelny, A. O., Hartman, M. C., and Szostak, J. W. (2011). Optimal codon choice can improve the efficiency and fidelity of N-methyl amino acid incorporation into peptides by in-vitro translation. Angew. Chem. Int. Ed. Engl. 50, 3164-3167. doi: 10.1002/anie.201007686
72. Ullman, C. G., Frigotto, L., and Cooley, R. N. (2011). In vitro methods for peptide display and their applications. Brief. Funct. Genomics 10, 125-134. doi: 10.1093/bfgp/elr010
73. Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., and Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615-2623. doi: 10.1021/jm020017n
74. Wang, C. K., Northfield, S. E., Swedberg, J. E., Colless, B., Chaousis, S., Price, D. A., et al. (2015). Exploring experimental and computational markers of cyclic peptides: charting islands of permeability. Eur. J. Med. Chem. 97, 202-213. doi: 10.1016/j.ejmech.2015.04.049
75. White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., et al. (2011). On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nat. Chem. Biol. 7, 810-817. doi: 10.1038/nchembio.664
76. Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., et al. (1996). Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273, 458-464.
77. Xiao, H., Murakami, H., Suga, H., and Ferré-D'Amaré, A. R. (2008). Structural basis of specific tRNA aminoacylation by a small in vitro selected ribozyme. Nature 454, 358-361. doi: 10.1038/nature07033